FDA Approved: CLOBAZAM — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLOBAZAM (clobazam), a generic seizure medication manufactured by Taro Pharmaceuticals U.S.A., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)